![Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials - eClinicalMedicine Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials - eClinicalMedicine](https://www.thelancet.com/cms/asset/70131966-e8a6-45f8-a757-289537cba066/gr1.jpg)
Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials - eClinicalMedicine
![Chocolate Touch drug-coated angioplasty balloon for treatment of PAD receives FDA approval - Vascular News Chocolate Touch drug-coated angioplasty balloon for treatment of PAD receives FDA approval - Vascular News](https://vascularnews.com/wp-content/uploads/sites/7/2022/11/Chocolate-DCB-766x512-300x201.jpg)
Chocolate Touch drug-coated angioplasty balloon for treatment of PAD receives FDA approval - Vascular News
![FDA deems Orchestra BioMed's sirolimus-eluting balloon a breakthrough device for coronary restenosis | Fierce Biotech FDA deems Orchestra BioMed's sirolimus-eluting balloon a breakthrough device for coronary restenosis | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1556303968/OrchestraBiomedVirtueSEB.jpg?VersionId=_q.ZV7ZqE1Yw22OzvAOeKWUNf6UnApJT)
FDA deems Orchestra BioMed's sirolimus-eluting balloon a breakthrough device for coronary restenosis | Fierce Biotech
![Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease | tctmd.com Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease | tctmd.com](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/2023-05/Concept%20Medical%20received%20IDE%20approval.jpg)
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease | tctmd.com
![Bard gets US FDA premarket approval for Lutonix 035 DCB in dysfunctional AV fistulae treatment - Interventional News Bard gets US FDA premarket approval for Lutonix 035 DCB in dysfunctional AV fistulae treatment - Interventional News](https://interventionalnews.com/wp-content/uploads/sites/13/2016/09/Lutonix-035_new-300x267.jpg)
Bard gets US FDA premarket approval for Lutonix 035 DCB in dysfunctional AV fistulae treatment - Interventional News
![Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group - ScienceDirect Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936879820308244-gr2.jpg)
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group - ScienceDirect
![Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon | Business Wire Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon | Business Wire](https://mms.businesswire.com/media/20230119005185/en/1680907/22/srmdx_logo_diamond_cmyk_590.jpg)